mail unicampaniaunicampania webcerca

    Michele GRIECO

    Insegnamento di MOLECULAR PATHOLOGY AND IMMUNOLOGY

    Corso di laurea magistrale in MOLECULAR BIOTECHNOLOGY

    SSD: MED/04

    CFU: 8,00

    ORE PER UNITÀ DIDATTICA: 64,00

    Periodo di Erogazione: Primo Semestre

    Italiano

    Lingua di insegnamento

    INGLESE

    Contenuti

    The course will focus on the Molecular mechanisms responsible for pathological phenomena and the role of the Immune response in human diseases. Oncology, Immunology and Immunopathology will be discussed.

    Testi di riferimento

    The latest edition of:
    Peter Parham “The immune system”
    Abul Abbas “Cellular and Molecular Immunology”
    Kennet Murphy “Janeway’s Immunobiology”

    Obiettivi formativi

    COURSE OBJECTIVES/OUTCOMES:
    To understand the molecular basis and the mechanisms leading to the onset of pathological phenomena in humans. To understand the role of the immune system in preventing disease.

    Prerequisiti

    B1 Knowledge of english

    Metodologie didattiche

    Frontal lessons

    Metodi di valutazione

    Oral examen to verify the accomplishment of the course objectives, especially for the understanding of the molecular mechanisms leading to pathological conditions.

    Altre informazioni

    ADDITIONAL READING:
    The cancer Immunotherapy mechanistic insights (J immunol monography 2018)
    Costa V et al “uncovering the complexity of transcriptomes with RNA seq (J immunol and Biotecnol. 2010)
    Metzker M “Sequencing technologies the next generation” (Nat Rev Gen 2009)
    Cossarizza A et al “Guidelines for the use of flow cytometry and cell sorting in immunological studies” (eur J Immunol 2017)

    Programma del corso

    SYLLABUS (Detailed description):
    Cells and Tissues of the Immune System
    Innate Immunity and Inflammation:
    Natural Killer Cells
    TLR signaling
    Cytokines and chemokines
    Adaptative Immunity:
    Antibody Structure and Antigens
    MHC Structure and Antigen Presentation
    Antigen Receptors and Accessory Molecules
    Lymphocyte Development and Expression of Antigen Receptors (BCR/TCR)
    B cell receptor . Structure and function of Immunoglobulins. Molecular Genetics. Antigen-antibody interactions.
    Regulation of the Immune Response
    Lymphocyte Activation and Signal Transduction
    Signal transduction to T lymphocytes. ITAM and phosphorylation.

    Immunopathology:
    Autoimmunity and Hypersensitivities
    Immune Deficiencies
    Immunological Tolerance

    Vaccines:
    Prophylactic and therapeutic vaccines. Role of humoral and cellular immune response. Correlates of protection. Impact and society concern. Side effects. Role of adjuvants. New generation vaccines.
    OMIC analyses. Next generation sequencing. Applications in the study of the immune response.
    T cell receptor. Molecular Genetics. The CD3 complex. Mechanisms of T cell recognition.
    Cytofluorimetry (principles and applications in the study of the immune response)
    Cancer Immunotherapy. Tumor associated antigens, tumor escape. Immuno-therapeutic markers and validated assays for monitoring the tumor-specific immune response. Adoptive T cell Therapy (CAR T and TCR).

    English

    Teaching language

    English

    Contents

    The course will focus on the Molecular mechanisms responsible for pathological phenomena and the role of the Immune response in human diseases. Oncology, Immunology and Immunopathology will be discussed.

    Textbook and course materials

    The latest edition of:
    Peter Parham “The immune system”
    Abul Abbas “Cellular and Molecular Immunology”
    Kennet Murphy “Janeway’s Immunobiology”

    Course objectives

    COURSE OBJECTIVES/OUTCOMES:
    To understand the molecular basis and the mechanisms leading to the onset of pathological phenomena in humans. To understand the role of the immune system in preventing disease.

    Prerequisites

    B1 Knowledge of english

    Teaching methods

    Frontal lessons

    Evaluation methods

    Oral examen to verify the accomplishment of the course objectives, especially for the understanding of the molecular mechanisms leading to pathological conditions.

    Other information

    ADDITIONAL READING:
    The cancer Immunotherapy mechanistic insights (J immunol monography 2018)
    Costa V et al “uncovering the complexity of transcriptomes with RNA seq (J immunol and Biotecnol. 2010)
    Metzker M “Sequencing technologies the next generation” (Nat Rev Gen 2009)
    Cossarizza A et al “Guidelines for the use of flow cytometry and cell sorting in immunological studies” (eur J Immunol 2017)

    Course Syllabus

    SYLLABUS (Detailed description):
    Cells and Tissues of the Immune System
    Innate Immunity and Inflammation:
    Natural Killer Cells
    TLR signaling
    Cytokines and chemokines
    Adaptative Immunity:
    Antibody Structure and Antigens
    MHC Structure and Antigen Presentation
    Antigen Receptors and Accessory Molecules
    Lymphocyte Development and Expression of Antigen Receptors (BCR/TCR)
    B cell receptor . Structure and function of Immunoglobulins. Molecular Genetics. Antigen-antibody interactions.
    Regulation of the Immune Response
    Lymphocyte Activation and Signal Transduction
    Signal transduction to T lymphocytes. ITAM and phosphorylation.

    Immunopathology:
    Autoimmunity and Hypersensitivities
    Immune Deficiencies
    Immunological Tolerance

    Vaccines:
    Prophylactic and therapeutic vaccines. Role of humoral and cellular immune response. Correlates of protection. Impact and society concern. Side effects. Role of adjuvants. New generation vaccines.
    OMIC analyses. Next generation sequencing. Applications in the study of the immune response.
    T cell receptor. Molecular Genetics. The CD3 complex. Mechanisms of T cell recognition.
    Cytofluorimetry (principles and applications in the study of the immune response)
    Cancer Immunotherapy. Tumor associated antigens, tumor escape. Immuno-therapeutic markers and validated assays for monitoring the tumor-specific immune response. Adoptive T cell Therapy (CAR T and TCR).

    facebook logoinstagram buttonyoutube logotype